You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恒指28,900获承接收窄逾半跌幅 美团升幅扩至逾9% 药明生物及石药升逾4%
阿思达克 05-31 15:01
港股继上周累涨665点或2.3%连升两周後,今早在港交所(00388.HK)、重磅股腾讯(00700.HK)、安踏(02020.HK)、药明生物(02269.HK)及季度营收倍增美团(03690.HK)支撑高开101点或近0.4%,报29,225欠承接,在金融板块回吐主导掉头曾倒跌214点,午後低见28,909喘定,现造29,022,仅倒跌102点或近0.4%,成交额1,118亿元。

55只蓝筹普遍下跌,尤其是友邦(01299.HK)重失20天、10天线(100.43元及101.98元)及「红底股」,最低见98.6元(刚为50天线),现造99.25元,回吐3.8%;汇控(00005.HK)和恒生(00011.HK)分别由逾14个月及16个月高位回吐3%及2.2%,分别低见49.1元(刚为10天线)及161.1元(险守10天线161.05元);中银(02388.HK)重失10天及20天线(28.25元及28.5元),最低见27.9元,现造28.05元,回吐1.9%。

回购建议获接纳上周五股价创16个月高的长实集团(01113.HK)、九仓置业(01997.HK)、百威亚太(01876.HK)、濠赌股金沙(01928.HK)和银娱(00027.HK)、电能(00006.HK)及申洲(02313.HK)也跌约2%-3%。

不过,港交所重越百天线(479.45元),最高见487.8元,现造483元,回升1.2%。腾讯扭两连跌,股价重越20天及10天线(603.5元),最高见612元,现造611.5元,回升1.7%。季度营收倍增获大行维持正面评级的美团午後升幅扩大,挑战50天线290.1元,最高见290.8元,现造290元,回升9.4%,结束两连跌。药明生物回升4.3%曾高见120.9元;上周获野村升价至13.7元的石药(01093.HK)回升4.1%曾高见12.34元创近三年高。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account